cash flow

Norwegian energy giant Equinor achieved record 2,137 mboe/day production in 2025 with $27.6B adjusted operating income, though safety incident raises concerns.

$UPS and $EPD offer attractive 6.7% and 5.8% yields respectively, with one positioned for operational turnaround and the other providing stable, fee-based infrastructure income.

Diageo, Campbell's, and Mondelez offer attractive dividend yields and valuations despite sector challenges, presenting compelling income opportunities.

Alphabet's massive $346B share repurchase program since 2016 has slashed outstanding shares by 13%, artificially boosting EPS independent of AI momentum.

Petco stock surged 52% after returning to profitability with improved cash flow and margins, but negative comparable sales and $1.5B debt warrant caution before chasing gains.

Tecan reported 2025 revenue of CHF 882.5M and net loss of CHF 110.7M from impairments, but launched 'Rewired' transformation targeting CHF 1B revenue and 20% EBITDA margin by 2028.

Swiss lab equipment maker Tecan reported 2025 loss amid impairment charges but unveiled transformation program targeting CHF 1 billion sales and 20% EBITDA margin by 2028.

$NIO reports first quarterly profit, beats expectations, delivers 72% YOY growth with 18% margins. Stock surges 10% on China's booming EV market outlook.

Diversified Energy declares Q3 2025 dividend of 29 cents per share, payable March 31, 2026, with sterling alternative at 21.471 pence.

Descartes Systems posts record fiscal 2026 results with $729M revenue (+12% YoY) and $163.8M net income, benefiting from supply chain complexity amid tariff uncertainty.

Pangaea Logistics ($PANL) reports strong Q4 2025 with 11% higher TCE rates and 23% EBITDA growth, declaring $0.05 dividend amid robust Arctic activity.

Bunge Global targets $15 EPS by 2030 and authorizes $3B buybacks, but 2026 guidance of $7.50-$8 trails analyst expectations.

Tenways files Hong Kong IPO to stabilize finances after three years of losses, recently achieving profitability amid slowing 3.1% revenue growth in maturing European e-bike market.

ZIM shares rose 2.80% despite missing earnings expectations, as investors focus on fleet modernization and pending Hapag-Lloyd acquisition at $35 per share.

Altria's proven profitability and 6.1% dividend outshine Tilray's persistent losses and shareholder dilution in cannabis sector comparison.

$GRMN soared 25.4% in February on record quarterly earnings across all segments and strong 2026 guidance, bolstered by dividend hikes and share buybacks.

Amarin's sole drug Vascepa faces generic competition, causing revenue to plummet 36% to $183 million in 2025, raising serious concerns about the company's single-product vulnerability.

Tesla's sustained profitability and diversified revenue streams separate it from cash-burning EV rivals Rivian and Lucid, creating a durable competitive advantage.

Three firms—Gilead Sciences, AbbVie, and Visa—offer defensive portfolios substantial free cash flow yields and capital returns amid 2026 market uncertainty.

Dell and Block generate strong positive cash flow and improve margins, while Lucid struggles with negative cash flow, negative gross margins, and substantial cash burn with profitability years away.